Furthermore, increased expression of ACSL4 has been observed in various tumor tissues, particularly in triple-negative breast cancer, and tumor cells with elevated ACSL4 expression may exhibit greater sensitivity to radiotherapy and chemotherapy [30]. The gene discussed is ACSL4; the disease is triple-negative breast carcinoma.